October 25th 2023
The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.
October 20th 2023
Huntsman Cancer Institute at the University of Utah and Utah Valley University proudly announce a groundbreaking partnership called the “Huntsman Cancer Institute–Utah Valley University Health Collaborative.”
August 28th 2023
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.
August 10th 2023
This month, researchers reduce the risk of infections after pancreatic surgery and discover the best cost-effective treatment combination for prostate cancer patients.
July 6th 2023
The Center for Health Outcomes and Population Equity at Huntsman Cancer Institute and the University of Utah, in partnership with the Montana State University Center for American Indian and Rural Health Equity, received a grant for Cancer Control in Persistent Poverty Areas from the National Cancer Institute.
June 26th 2023
Huntsman Cancer Institute at the University of Utah, a pioneering innovator dedicated to developing more effective ways to care for and prevent cancer, announced plans today for a new Huntsman Cancer Institute comprehensive cancer center in Utah County.
June 20th 2023
In a recently published manuscript, Howard Colman, MD, PhD, identified a potential breakthrough in glioblastoma treatment.
May 18th 2023
Huntsman Cancer Institute at the University of Utah, the only place in the region devoted to developing new treatments for cancer, announced the opening of the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women’s Cancers.
April 4th 2023
Neeraj Agarwal, MD, is now a distinguished member of the Fellows of the American Society of Clinical Oncology.
March 28th 2023
TALAPRO-2 demonstrated that using talazoparib in combination with enzalutamide may reduce the risk of disease progression or death by 37%.
March 21st 2023
Varghese, known for his innovative research in perioperative care and mentorship to physician-scientists, will become SUS President in February 2024.
February 27th 2023
Huntsman Cancer Institute at the University of Utah congratulates three of their newest endowed chairs.
November 28th 2022
Regular physical activity can extend the lives of patients with colorectal cancer, according to a study looking at the impact of exercise on the gut microbiome of cancer patients.